Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04192773 · ClinicalTrials.gov registry record · Early Phase 1

An fMRI Investigation of the Effects of IV Lidocaine on Tinnitus

A Early Phase 1 study of Tinnitus, sponsored by D. Bradley Welling, MD, PhD.

Recruiting
Registry status
Early Phase 1
Development phase
40
Enrollment target
1
Study location

NCT04192773 is a Early Phase 1 study of Tinnitus that is actively recruiting participants, run by D. Bradley Welling, MD, PhD. The registered enrollment target is 40 participants, below the 12,618-participant average among 24 other Tinnitus trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04192773, a Early Phase 1 study of Tinnitus, is actively recruiting participants, sponsored by D. Bradley Welling, MD, PhD.

RECRUITING
Registry status
Early Phase 1
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This is an exploratory pilot open-label study to identify the signal changes on fMRI of patients with tinnitus and with temporary suppression of the tinnitus with IV lidocaine. Patients will include those with hearing loss (both unilateral and bilateral) and tinnitus, subjects with normal hearing and tinnitus, and control subjects with normal hearing and no tinnitus. Eligible subjects will have functional and subjective data collected at baseline, receive an IV lidocaine infusion, and have functional and subjective data collected post-infusion for comparison and identification of involved neural networks.

Conditions Studied

Interventions

  • DRUG IV Lidocaine

Study Locations (1)

Massachusetts

  • Massachusetts Eye and Ear Infirmary - Boston

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2021-04-28
Est. Completion 2027-12-31
Phase Early Phase 1

Sponsor

D. Bradley Welling, MD, PhD

3 total trials

What the Registry Record Tells You About NCT04192773

The ClinicalTrials.gov registry entry for NCT04192773 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,618-participant average among 24 other Tinnitus trials with a reported enrollment target (100% lower). The listed sponsor is D. Bradley Welling, MD, PhD, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Tinnitus appearing as the primary indexed condition, and to 1 intervention - of which IV Lidocaine is the first listed.

NCT04192773 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04192773 about?

NCT04192773 is a clinical study titled "An fMRI Investigation of the Effects of IV Lidocaine on Tinnitus". This is an exploratory pilot open-label study to identify the signal changes on fMRI of patients with tinnitus and with temporary suppression of the tinnitus with IV lidocaine. Patients will include those with hearing loss (both unilateral and bilateral) and tinnitus, subjects with normal hearing an...

What is the current status of trial NCT04192773?

This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 40 participants. The study started on 2021-04-28. Estimated completion is 2027-12-31.

What conditions does trial NCT04192773 study?

This clinical trial studies the following conditions: Tinnitus.

What interventions are being tested in trial NCT04192773?

The interventions under investigation include: IV Lidocaine (DRUG).

Who is sponsoring clinical trial NCT04192773?

This trial is sponsored by D. Bradley Welling, MD, PhD, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04192773 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tinnitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.